programmed cell death-1 - Globe Thesis

Keyword [programmed cell death-1] Result: 41 - 59 \| Page: 3 of 3
41.	Safety Evaluation Of Clinical Application Of Programmed Cell Death-1 Inhibitors
42.	Exploration Of The Value And Mechanism Of TP53 Gene As A Predictive Biomarker For Targeted Therapy And Immunotherapy In Non-small Cell Lung Cancer
43.	Targeting Atherogenic T-cells As A Novel Therapeutic In Reducing Atherosclerosis In Humans
44.	Efficacy And Molecular Mechanism Of Neoantigen Peptides Vaccine Combined With PD-1 Blockade Against Hepatocellular Carcinoma
45.	Study On The Expression And Function Of Programmed Cell Death 1 Ligand 2(PD-L2)in Colorectal Cancer
46.	CT-based Radiomics Combined With Deep Learning Strategy To Predict The Efficacy Of Immunotherapy For Lung Cancer
47.	The Expression Status And Biological Function Of PD-L2 In Head And Neck Squamous Cell Carcinoma
48.	Efficacy And Safety Analysis Of PD-1 Inhibitor Combined With Recombinant Human Endostatin And Chemotherapy In First-Line Treatment Of Advanced Non-small Cell Lung Cancer
49.	Clinical Efficacy And Safety Analysis Of Receiving PD-1 Inhibitor-containing Regimen In Elderly Patients With Advanced Gastric Cancer
50.	The Mechanism Of PD-1 Regulation Of Glycolysis-mediated T Lymphocyte Dysfunction In Acute-on-chronic Liver Failure
51.	PD-1 Inhibitors Participate In The Occurrence And Development Of Myocarditis By Influencing Intestinal Flora
52.	The Significance Of Lymphocyte Subsets And PD-1/PD-L1 In Ulcerative Colitis
53.	Expression Of PD-1/PD-L1 In Different Histological Subtypes Of Nasopharyngeal Carcinoma And Its Clinical Significance
54.	Identification And Mechanism Of Novel PD-L1-related CircRNA/miRNA/mRNA CeRNA Network In Head And Neck Squamous Cell Carcinoma Based On Whole Transcriptomics
55.	The Application Of Immune Checkpoint Inhibitors In Unresectable Hepatocellular Carcinoma:Clinical Exploration And A Meta-Analysis Of Prognosis
56.	Construction Of PD-L1~+ Cell Membrane-coated Bionanoparticles And Effects On The Immune Microenvironment Of Thyroid Associated Ophthalmopathy
57.	Radiomics Analysis Based On MR Imaging For Prediction Of PD-L2 Expression In Hepatocellular Carcinoma
58.	Clinical Efficacy Analysis And Prediction Of Pegylated Interferon In Nucleoside Analogue Experienced Negative HBeAg Chronic Hepatitis B
59.	Mitochondrial PD-L1 Mediated Metabolic Reprogramming Involved In Ferroptosis Sensitivity Of Liver Cancer Stem Cells Regulated By Tumor Microenvironment
<<First <Prev Next> Last>> Jump to